- Home
- ARCT vs LDP Comparison
ARCT vs LDP Comparison
Compare ARCT & LDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- LDP
- Stock Information
- Founded
- ARCT 2013
- LDP 2012
- Country
- ARCT United States
- LDP United States
- Employees
- ARCT N/A
- LDP N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- LDP Finance Companies
- Sector
- ARCT Health Care
- LDP Finance
- Exchange
- ARCT Nasdaq
- LDP Nasdaq
- Market Cap
- ARCT 298.3M
- LDP 556.9M
- IPO Year
- ARCT N/A
- LDP N/A
- Fundamental
- Price
- ARCT $13.78
- LDP $21.25
- Analyst Decision
- ARCT Strong Buy
- LDP
- Analyst Count
- ARCT 8
- LDP 0
- Target Price
- ARCT $52.83
- LDP N/A
- AVG Volume (30 Days)
- ARCT 474.9K
- LDP 102.5K
- Earning Date
- ARCT 08-04-2025
- LDP 01-01-0001
- Dividend Yield
- ARCT N/A
- LDP 7.91%
- EPS Growth
- ARCT N/A
- LDP N/A
- EPS
- ARCT N/A
- LDP N/A
- Revenue
- ARCT $143,680,000.00
- LDP N/A
- Revenue This Year
- ARCT N/A
- LDP N/A
- Revenue Next Year
- ARCT $34.79
- LDP N/A
- P/E Ratio
- ARCT N/A
- LDP N/A
- Revenue Growth
- ARCT 15.38
- LDP N/A
- 52 Week Low
- ARCT $8.04
- LDP $16.16
- 52 Week High
- ARCT $25.88
- LDP $20.30
- Technical
- Relative Strength Index (RSI)
- ARCT 54.34
- LDP 72.26
- Support Level
- ARCT $13.10
- LDP $21.01
- Resistance Level
- ARCT $15.20
- LDP $21.37
- Average True Range (ATR)
- ARCT 1.02
- LDP 0.14
- MACD
- ARCT 0.07
- LDP 0.02
- Stochastic Oscillator
- ARCT 55.21
- LDP 83.33
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.